Janssen Pharma’s Byannli (PP6M) receives European approval for Maintenance Treatment of Schizophrenia in Adults.
KEYPOINTS: Janssen has won approval from the European Commission for Byannli, a six-month formulation of Paliperidone Palmitate, two months after receiving a…